Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Norton

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Teratology|December 31, 1997
Teratogen update: fetal effects of indomethacin administration during pregnancyM E Norton
Seminars in Perinatology|August 1, 1994
Biochemical and ultrasound screening for chromosomal abnormalitiesM E Norton
BJOG : an International Journal of Obstetrics and Gynaecology|March 17, 2017
Prenatal screening: it is not just about Down syndromeM E Norton
Seminars in Perinatology|August 1, 1994
Nonimmune hydrops fetalisM E Norton
Journal of Perinatology : Official Journal of the California Perinatal Association|July 1, 1997
Behçet's syndrome associated with intrauterine growth restriction: a case report and review of the literatureG Guzelian, M E Norton
The American Journal of the Medical Sciences|June 1, 1989
Changes in functional status during pregnancyK L Ales, M E Norton
Prenatal Diagnosis|September 1, 1992
Maternal serum CA 125 for aneuploidy detection in early pregnancyM E Norton, M S Golbus
Obstetrics and Gynecology|November 27, 1999
Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutationA F Bosco, M E Norton, E Lieberman
The Journal of Pediatrics|May 1, 1994
Indomethacin as a tocolytic agent: the controversy continuesJ D Merrill, R I Clyman, M E Norton
Journal of Clinical Epidemiology|January 1, 1990
The clinical significance of predictions based on screening second trimester mean arterial pressure: adverse maternal [corrected] and infant outcomesK L Ales, M E Norton, M L Druzin
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Teratology|December 31, 1997
Teratogen update: fetal effects of indomethacin administration during pregnancyM E Norton
Seminars in Perinatology|August 1, 1994
Biochemical and ultrasound screening for chromosomal abnormalitiesM E Norton
BJOG : an International Journal of Obstetrics and Gynaecology|March 17, 2017
Prenatal screening: it is not just about Down syndromeM E Norton
Seminars in Perinatology|August 1, 1994
Nonimmune hydrops fetalisM E Norton
Journal of Perinatology : Official Journal of the California Perinatal Association|July 1, 1997
Behçet's syndrome associated with intrauterine growth restriction: a case report and review of the literatureG Guzelian, M E Norton
The American Journal of the Medical Sciences|June 1, 1989
Changes in functional status during pregnancyK L Ales, M E Norton
Prenatal Diagnosis|September 1, 1992
Maternal serum CA 125 for aneuploidy detection in early pregnancyM E Norton, M S Golbus
Obstetrics and Gynecology|November 27, 1999
Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutationA F Bosco, M E Norton, E Lieberman
The Journal of Pediatrics|May 1, 1994
Indomethacin as a tocolytic agent: the controversy continuesJ D Merrill, R I Clyman, M E Norton
Journal of Clinical Epidemiology|January 1, 1990
The clinical significance of predictions based on screening second trimester mean arterial pressure: adverse maternal [corrected] and infant outcomesK L Ales, M E Norton, M L Druzin
Pageof 4